Semaglutide vs Tirzepatide: Comparing GLP-1 Weight Loss Medications
GLP-1 receptor agonists have revolutionized medical weight loss. Semaglutide (the active ingredient in Wegovy and Ozempic) and tirzepatide (Mounjaro/Zepbound) are the two most prominent options. Here’s what you need to know about each, from the weight loss specialists at Naya Aesthetics & Wellness.
How Do They Work?
Semaglutide
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist. It mimics the naturally occurring GLP-1 hormone, which reduces appetite, slows gastric emptying (making you feel full longer), and helps regulate blood sugar levels. It was originally developed for type 2 diabetes management and later approved for weight management.
Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates two incretin hormone receptors instead of one. This dual action may provide enhanced appetite suppression and improved blood sugar control compared to GLP-1-only medications.
Weight Loss Results
Clinical trials have shown significant weight loss with both medications. The STEP trials showed semaglutide patients losing an average of 15-17% of body weight over 68 weeks. The SURMOUNT trials for tirzepatide showed even greater average weight loss of 20-26% of body weight, depending on the dose.
Side Effects
Both medications share similar gastrointestinal side effects, including nausea (the most common), vomiting, diarrhea, and constipation. These side effects are typically mild and improve as the body adjusts. Both medications are started at low doses and gradually increased to minimize side effects.
Administration
Both semaglutide and tirzepatide are administered as weekly subcutaneous injections. Treatment typically begins at a low dose and increases over several weeks to reach the therapeutic dose.
Cost and Availability
Brand-name versions of both medications can be expensive without insurance. Compounded versions of semaglutide are available through medical weight loss clinics at more accessible price points. Availability and pricing vary by provider and location.
Which Is Right for You?
The best GLP-1 medication depends on your individual health profile, weight loss goals, medical history, and budget. While tirzepatide has shown slightly greater average weight loss in clinical trials, individual responses vary significantly. A medical evaluation is essential to determine the safest and most effective option for you.
At Naya Aesthetics & Wellness in Chatsworth, CA, our physician-supervised weight loss program includes comprehensive evaluation, lab work, and personalized medication selection. We offer semaglutide programs with ongoing monitoring and support. Schedule a weight loss consultation or call (818) 341-8888.
Naya Wellness offers clinically supervised semaglutide and tirzepatide weight loss programs in Chatsworth, CA. Our providers will help you choose the right medication based on your health history and goals.
Naya Wellness offers clinically supervised semaglutide and tirzepatide weight loss programs in Chatsworth, CA. Our providers will help you choose the right medication based on your health history and goals.
Semaglutide vs Tirzepatide FAQ
What is the difference between semaglutide and tirzepatide?
Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual GIP/GLP-1 receptor agonist that activates two incretin pathways instead of one, which may provide enhanced appetite suppression and blood sugar control.
How much weight can you lose on semaglutide vs tirzepatide?
In clinical trials, semaglutide patients lost an average of 15–17% of body weight over 68 weeks (STEP trials). Tirzepatide showed greater average weight loss of 20–26% (SURMOUNT trials), though individual responses vary significantly.
What are the side effects of semaglutide and tirzepatide?
Both share similar gastrointestinal side effects: nausea (most common), vomiting, diarrhea, and constipation. Side effects are typically mild and improve as the body adjusts. Both are started at low doses and titrated up.
How are semaglutide and tirzepatide administered?
Both are administered as weekly subcutaneous injections. Treatment typically begins at a low dose and increases over several weeks to reach the therapeutic dose.
Which is better, semaglutide or tirzepatide?
Tirzepatide has shown slightly greater average weight loss in trials, but individual response, medical history, and tolerability vary. A medical evaluation is essential to determine the right GLP-1 for your goals.